Brain networks and clinical penetrance: lessons from hyperkinetic movement disorders.
Eidelberg
David
D
D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism; D002352:Carrier Proteins / Q000235:genetics; D004422:Dystonia Musculorum Deformans / Q000000981:diagnostic imaging / Q000235:genetics; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics; D006801:Humans; D006816:Huntington Disease / Q000000981:diagnostic imaging / Q000235:genetics; D006948:Hyperkinesis / Q000000981:diagnostic imaging* / Q000235:genetics* / Q000378:metabolism; D018832:Molecular Chaperones; D009415:Nerve Net / Q000000981:diagnostic imaging* / Q000378:metabolism; D011859:Radiography; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D014055:Tomography, Emission-Computed
D002352:Carrier Proteins; D018832:Molecular Chaperones; D019275:Radiopharmaceuticals; C108175:TOR1A protein, human; D019788:Fluorodeoxyglucose F18